Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Rho family GTPases, specifically RhoA (Ras homolog family member A), Rac1 (Ras-related C3 botulinum toxin substrate 1), and Cdc42 (Cell division control protein 42 homolog), are critical molecular switches that regulate the actin cytoskeleton and various signal transduction pathways. These proteins cycle between an inactive GDP-bound state and an active GTP-bound state, a process tightly controlled by guanine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs), and guanine nucleotide dissociation inhibitors (GDIs). RhoA is primarily responsible for the formation of stress fibers and focal adhesions, while Rac1 and Cdc42 drive the formation of lamellipodia and filopodia, respectively, facilitating cell motility and polarity. Beyond their roles in cytoskeletal dynamics, they are involved in cell cycle regulation, gene transcription, and vesicle trafficking. In many diseases, particularly cancer, these GTPases are often overexpressed or hyperactivated, contributing to tumor growth, invasion, and metastasis. Therapeutic strategies targeting these molecules include small-molecule inhibitors that disrupt GEF interactions, block nucleotide binding, or prevent post-translational lipid modifications necessary for membrane localization.
Inhibition of Guanine nucleotide Exchange Factor (GEF) interaction, competitive or non-competitive inhibition of GTP binding, inhibition of post-translational geranylgeranylation, and inhibition of downstream effector kinases such as ROCK and PAK.
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ras homolog family member A, Ras-related C3 botulinum toxin substrate 1, and Cell division control protein 42 homolog (RhoA/Rac1/Cdc42).